Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andreas Eisenmenger"'
Autor:
Anton, Schestakow, Norbert, Pütz, Moritz Simon, Guth, Tobias Andreas, Eisenmenger, Johanna, Dudek, Matthias, Hannig
Publikováno v:
Archives of Oral Biology. 136:105388
The aim of the present in-situ study was to investigate anti-adherent properties of mouthrinses containing hydroxyapatite (HAP) nanoparticles on oral biofilm formation.Biofilm was formed for 48 h on bovine enamel or dentine specimens that were fixed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3781296de3069a2a6b4743343edef38
https://doi.org/10.1016/j.archoralbio.2022.105388
https://doi.org/10.1016/j.archoralbio.2022.105388
Autor:
Martin Bendszus, Andreas von Deimling, Antje Wick, Irini Karapanagiotou-Schenkel, Jürgen Debus, David T.W. Jones, Andreas Unterberg, Frank Winkler, Michael Platten, Elke Pfaff, Wolfgang Wick, Andreas Eisenmenger, Christel Herold-Mende, Anne Berberich, Susan Dettmer, Benedikt Brors, Tobias Kessler, Stefan M. Pfister, Felix Sahm
Publikováno v:
Neuro-Oncology. 21:95-105
Background Patients with glioblastoma without O6-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation are unlikely to benefit from alkylating chemotherapy with temozolomide (TMZ). Trials aiming at replacing TMZ with targeted agents in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45de6b8c0762df08aca119506aa8d76
https://doi.org/10.1093/neuonc/noy161
https://doi.org/10.1093/neuonc/noy161
Autor:
Sylvie Lorenzen, Ulrike Helbig, Florian Weißinger, G.M. Haag, Michael Pohl, Josef Rüschoff, Elisabeth Schnoy, Jorge Riera Knorrenschild, Gertraud Stocker, Klaus Becker, Andreas Eisenmenger, Florian Bassermann, Peter C. Thuss-Patience, Irini Karapanagiotou-Schenkel, Florian Lordick
Publikováno v:
European Journal of Cancer. 51:569-576
Introduction Human epidermal growth factor receptor 2 (HER2) amplification is present in a subgroup of gastroo-esophageal cancers (GCs). HER2 inhibition with trastuzumab has shown to improve outcomes in advanced disease. Lapatinib ditosylate (LAP), a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873a49a469a6f8c7ca14d8c2168d92bb
https://doi.org/10.1016/j.ejca.2015.01.059
https://doi.org/10.1016/j.ejca.2015.01.059
Autor:
Jürgen Debus, David T.W. Jones, Christel Herold-Mende, Gnana Prakash Balasubramanian, Felix Sahm, Andreas Unterberg, Irini Schenkel, Benedikt Brors, Tobias Kessler, Wolfgang Wick, Michael Platten, Stefan M. Pfister, David Capper, Andreas von Deimling, Antje Wick, Anne Berberich, Susan Dettmer, Daniel Schrimpf, Martin Bendszus, Elke Pfaff, Andreas Eisenmenger
Background O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a predictive biomarker in glioblastoma patients. Glioblastoma without hypermethylated MGMT promoter is largely resistant to treatment with temozolomide. These pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e73948e7f065d70815121cf103d573
https://europepmc.org/articles/PMC5961072/
https://europepmc.org/articles/PMC5961072/
Autor:
Waldemar Waldeck, Andreas Eisenmenger, Gerd Wolber, Klaus Braun, Isabell Braun, Ralf Rastert, Joürgen Debus, Stefan Heckl, Rüdiger Pipkorn, Jürgen Jenne, Heike Corban-Wilhelm, Volker Ehemann
Publikováno v:
European Journal of Medicinal Chemistry. 38:587-595
Boron neutron capture therapy (BNCT) is an experimental treatment modality which depends on a sufficient cellular uptake of Boron ((10)B) followed by an exposure to a thermal neutron beam from a nuclear reactor. High energetic particles (4He and 7Li)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ed42a6699ef94ce098993d05a3c421c
https://doi.org/10.1016/s0223-5234(03)00088-6
https://doi.org/10.1016/s0223-5234(03)00088-6
Autor:
Andreas von Deimling, Christel Herold-Mende, Antje Wick, Andreas Eisenmenger, Martin Bendszus, Barbara Hutter, Andreas Unterberg, Benedikt Brors, Felix Sahm, Michael Platten, Wolfgang Wick, David T.W. Jones, Anne Hertenstein, Matthias Osswald, Elke Pfaff, Sarah Loew, Irini Karapanagiotou-Schenkel, Juergen Debus, Stefan M. Pfister
Publikováno v:
Journal of Clinical Oncology. 34:TPS2084-TPS2084
TPS2084Background: Patients with newly diagnosed glioblastoma without O6-methyl guanine O6-methylatransferase (MGMT) promoter methylation do not benefit from alkylating therapy. Clinical trials aiming at replacing temozolomide (TMZ) with targeted age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba96f909a30dd37bdb457ef86301d887
https://doi.org/10.1200/jco.2016.34.15_suppl.tps2084
https://doi.org/10.1200/jco.2016.34.15_suppl.tps2084
Publikováno v:
Angewandte Chemie International Edition. 42:3425-3427
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f900bef549fe52f49a829841469acb36
https://doi.org/10.1002/anie.200250547
https://doi.org/10.1002/anie.200250547
Autor:
Katja Ickstadt, Thorsten Wiethege, H. Wesch, Beate Pesch, Thomas Brüning, Georg Johnen, Dirk Taeger, Andreas Eisenmenger, Ulrike Krahn
Publikováno v:
Journal of toxicology and environmental health. Part A. 71(13-14)
Between 1946 and 1990 uranium mining was undertaken on a large scale in East Germany. This study evaluates the proportional lung cancer risk of German uranium miners from radon, quartz, and arsenic exposure during mining operations at the WISMUT Corp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::241420d1001be6e7511fcb8b13fe60b8
https://pubmed.ncbi.nlm.nih.gov/18569586
https://pubmed.ncbi.nlm.nih.gov/18569586
Autor:
Elisabeth Schnoy, Andreas Eisenmenger, Ulrike Helbig, Jorge Riera-Knorrenschild, Michael Pohl, Peter C. Thuss-Patience, Gertraud Stocker, Josef Rüschoff, Florian Lordick, Klaus Becker, Sylvie Lorenzen, Florian Weissinger, Florian Bassermann, Irini Karapanagiotou-Schenkel, Georg Martin Haag
Publikováno v:
Journal of Clinical Oncology. 33:112-112
112 Background: HER2 amplification is present in a subgroup of gastroesophageal cancers (GCs). HER2 inhibition with trastuzumab has shown to improve outcomes in advanced disease. Lapatinib ditosylate (LAP), a dual anti-EGFR and anti-HER2 tyrosine kin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::556301cf186eccd346bdf403ac16c8de
https://doi.org/10.1200/jco.2015.33.3_suppl.112
https://doi.org/10.1200/jco.2015.33.3_suppl.112
Autor:
Beate Pesch, Georg Johnen, Yon Ko, Thorsten Wiethege, H. Wesch, Thomas Bruning, Andreas Eisenmenger, Arno Fritsch, Klaus Michael Muller, Dirk Taeger, Sebastian Stier
Publikováno v:
Cancer. 106(4)
BACKGROUND In East Germany, uranium mining was undertaken on a large scale from 1946 to 1990. Poor working conditions led to a high level of exposure to ionizing radiation and quartz dust. This analysis evaluates the histopathology of lung carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf67992983d398046bb49732420b2506
https://pubmed.ncbi.nlm.nih.gov/16411224
https://pubmed.ncbi.nlm.nih.gov/16411224